Weight on 0.75 (0.75, Q Fixed 0.72) Categorical covariates effects (NULL effect = 1) Prior 1.04 (1.01, 1.07) antagonist therapy status on CLL ADA status 1.12 (1.05, on CLL 1.2) AZA on 0.998 (0.964, CLL 1.03)
Weight on Q 0.75 Fixed (0.75, 0.72) Categorical covariates effects (NULL effect = 1) Prior antagonist therapy status on CLL 1.04 (1.01, 1.07) ADA status on CLL 1.12 (1.05, 1.2) AZA on CLL 0.998 (0.964, 1.03)